Analystreport

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview